Our Immune Pan-antigen Cytotoxic Therapy (ImPACT) platform is a cell-based, T-cell-stimulating platform that functions as an immune activator to stimulate T-cells.

ImPACT reprograms a live, genetically modified cancer cell line to continually secrete the heat-shock protein, gp96. Once the cell line is injected into the body along with a checkpoint inhibitor, they are bound to the cell’s own mutated antigens bound to gp96.

ImPACT Technology

Learn how ImPACT Technology works


The Immune System’s Swiss Army Knife*

*Schild H., Rammensee H. gp96-The immune system’s Swiss army knife. Nature Immunol. 1, 100-101 (2000).


Our T-cell stimulating platform